Your browser doesn't support javascript.
loading
Evaluating the potential of relapse-free survival as a surrogate for overall survival in the adjuvant therapy of melanoma with checkpoint inhibitors.
Coart, Elisabeth; Suciu, Stefan; Squifflet, Pierre; Saad, Everardo D; Moshyk, Andriy; de Schaetzen, Gaetan; Buyse, Marc; Weber, Jeffrey S; Eggermont, Alexander; Kotapati, Srividya.
Afiliação
  • Coart E; International Drug Development Institute (IDDI), Avenue Provinciale, 30, 1340, Louvain-la-Neuve, Belgium. Electronic address: elisabeth.coart@iddi.com.
  • Suciu S; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Squifflet P; International Drug Development Institute (IDDI), Avenue Provinciale, 30, 1340, Louvain-la-Neuve, Belgium.
  • Saad ED; International Drug Development Institute (IDDI), Avenue Provinciale, 30, 1340, Louvain-la-Neuve, Belgium.
  • Moshyk A; Health Economics and Outcomes Research, Bristol Myers Squibb, 100 Nassau Park Blvd, Princeton, NJ, 08540, USA.
  • de Schaetzen G; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Buyse M; International Drug Development Institute (IDDI), Avenue Provinciale, 30, 1340, Louvain-la-Neuve, Belgium.
  • Weber JS; Laura and Isaac Perlmutter Cancer Center, NYU School of Medicine, 522 First Avenue, New York, NY, 10016, USA.
  • Eggermont A; Princess Maxima Center, Utrecht, the Netherlands.
  • Kotapati S; Health Economics and Outcomes Research, Bristol Myers Squibb, 100 Nassau Park Blvd, Princeton, NJ, 08540, USA.
Eur J Cancer ; 137: 171-174, 2020 09.
Article em En | MEDLINE | ID: mdl-32777716
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Quimioterapia Adjuvante / Inibidores de Checkpoint Imunológico / Melanoma Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Quimioterapia Adjuvante / Inibidores de Checkpoint Imunológico / Melanoma Idioma: En Ano de publicação: 2020 Tipo de documento: Article